ELISpot assay to immune phenotype patients

by | May 19, 2021 | Hotchkiss, Richard, Mazer, Monty, Remy, Kenneth, Turnbull, Isaiah

— Technology Description

A team of researchers, led by Richard Hotchkiss at Washington University in St. Louis, have developed a version of the ELISpot assay to determine if COVID-19 patients are in a hyper-inflammatory or immunosuppressed state. The results of this assay, which can be performed wit…